Hydroxymatairesinol in cancer prevention
CA 2371839 C · Owner: Hormos Medical Ltd. · Inventors: Makela, Sari; Kangas, Lauri; Santti, Risto
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to methods for prevention of cancers certain non-, cancer, hormone dependent diseases and/or cardiovascular diseases in a person based on administering of hydroxymatairesinol to said person. The invention also concerns a method for increasing the level of enterolactone or another metabolite of hydroxymatairesinol in a person's serum thereby causing prevention of a cancer or a certain non-cancer hormone dependent disease in a , person based on administering of hydroxymatairesinol to said person. Furthermore, this invention relates to pharmaceutical preparations food , additives and food products comprising hydroxymatairesinol.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 9, 2000 and granted October 4, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 9, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 9, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.